Tirzepatide Raw Material
Tirzepatide Raw Material
Tirzepatide Raw Material
Tirzepatide Raw Material
Tirzepatide Raw Material
Tirzepatide Raw Material
Haga clic en el espacio vacío para volver

Tirzepatide Raw Material

Tirzepatide is a novel dual GIP and GLP-1 receptor agonist showing significant promise in the treatment of type 2 diabetes and obesity. By mimicking the action of these incretin hormones, Tirzepatide enhances insulin secretion, inhibits glucagon release, and promotes weight loss. This dual action not only addresses blood glucose levels but also supports weight management, positioning Tirzepatide as a groundbreaking option for metabolic disease management. Our high-purity Tirzepatide raw material is aimed at supporting research into its efficacy, mechanisms of action, and potential broader applications in metabolic syndrome and cardiovascular risk reduction.

  • Descripción